Press release
Lipid-lowering Drugs Market to Surpass US$ 42.5 Billion by [2031]: Rising Demand for Cardiovascular Risk Management Fuels Growth - Transparency Market Research Inc.
Lipid-lowering Drugs
Market Overview The global lipid-lowering drugs market was valued at US$ 31.4 billion in 2022 and is projected to expand at a CAGR of 3.4% from 2023 to 2031. By 2031, the market is expected to exceed US$ 42.5 billion. Growth is driven by an aging population, rising obesity rates, and an increasing prevalence of cardiovascular diseases worldwide.
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85507
Analyst Viewpoint
Market analysts anticipate steady growth in the lipid-lowering drugs sector, supported by increasing healthcare expenditures and advancements in drug formulations. The market is witnessing a shift toward combination therapies and biologic treatments that offer enhanced efficacy. However, patent expirations of major drugs and pricing pressures from generic competition may hinder market growth to some extent.
Market Demand and Key Drivers
Rising Cardiovascular Disease Prevalence: Increasing cases of hypercholesterolemia and related cardiovascular disorders drive demand.
Aging Population: Elderly individuals are at higher risk of high cholesterol and heart diseases, necessitating effective lipid management.
Obesity and Sedentary Lifestyles: Poor dietary habits and lack of physical activity contribute to hyperlipidemia, boosting demand for lipid-lowering drugs.
Advancements in Drug Development: Introduction of PCSK9 inhibitors and novel combination therapies improve treatment efficacy.
Government Initiatives and Public Health Awareness: Increasing focus on preventive healthcare and early cholesterol management propels the market.
Growing Adoption of Biologics: Monoclonal antibodies targeting cholesterol pathways are gaining traction due to their high effectiveness.
Recent Developments
2023, Amgen Inc.: Expanded the availability of its PCSK9 inhibitor Repatha in emerging markets.
2023, Merck & Co., Inc.: Announced promising Phase III clinical trial results for a next-generation statin.
2024, Pfizer Inc.: Entered a collaboration to develop an innovative lipid-lowering combination therapy.
2024, Novartis AG: Launched a new oral drug for cholesterol management targeting hard-to-treat patients.
2024, AstraZeneca: Secured FDA approval for a novel lipid-lowering biologic therapy.
Key Market Players
Sanofi
Pfizer, Inc.
GlaxoSmithKline plc
Novartis AG
Merck & Co., Inc.
Amgen Inc.
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd.
AbbVie, Inc.
Viatris (Mylan N.V.)
AstraZeneca PLC
Dr. Reddy's Laboratories Ltd.
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85507
Future Market Analysis
The lipid-lowering drugs market is poised for consistent growth due to increasing cardiovascular disease prevalence and innovations in drug development. While generic competition and regulatory challenges may impact pricing, continued research in biologics, gene therapies, and AI-driven drug discovery will shape the future of cholesterol management. The growing emphasis on personalized medicine and preventive healthcare strategies is expected to further drive the market.
Market Trends and Opportunities
Emergence of PCSK9 Inhibitors: These biologics are revolutionizing cholesterol treatment by providing long-term LDL reduction.
Combination Therapies on the Rise: Fixed-dose combinations of statins with other lipid-lowering agents offer enhanced patient compliance.
Development of RNA-based Therapies: Innovative treatments targeting lipid metabolism at the genetic level are gaining interest.
Increased Focus on Preventive Healthcare: Proactive cholesterol monitoring and early intervention are creating new market opportunities.
Expansion in Emerging Markets: Growing healthcare access in developing nations is increasing adoption of lipid-lowering drugs.
Market Segmentation
By Drug Class:
Statins
PCSK9 Inhibitors
Bile Acid Sequestrants
Cholesterol Absorption Inhibitors
Fibric Acid Derivatives
Omega-3 Fatty Acid Derivatives
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Indication:
Hypercholesterolemia
Hyperlipidemia
Familial Hypercholesterolemia
Others
Regional Analysis
North America: Leads the market due to high prevalence of cardiovascular diseases and well-established healthcare infrastructure.
Europe: Significant growth driven by an aging population and increasing awareness of cholesterol management.
Asia-Pacific: Fastest-growing region due to rising lifestyle diseases, increasing healthcare spending, and expanding pharmaceutical access.
Latin America & Middle East/Africa: Emerging markets with rising awareness and accessibility to lipid-lowering treatments.
Explore Latest Research Reports by Transparency Market Research:
Topical Antibiotics Market: https://www.pharmiweb.com/press-release/2025-03-14/topical-antibiotics-market-to-reach-100-billion-by-2035-driven-by-51-cagr-and-innovations-in-antimicrobial-therapies-exclusive-reports-by-tmr-i
Diagnostic Specialty Enzymes Market: https://www.pharmiweb.com/press-release/2025-03-14/diagnostic-specialty-enzymes-market-to-expand-at-a-cagr-of-69-and-reach-us-18-bn-by-2035-exclusive-reports-by-tmr-insights
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
Headquarters Downtown,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Phone: +1-518-618-1030
US - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lipid-lowering Drugs Market to Surpass US$ 42.5 Billion by [2031]: Rising Demand for Cardiovascular Risk Management Fuels Growth - Transparency Market Research Inc. here
News-ID: 3935881 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
